No Data
Express News | Needham Reiterates Buy on CRISPR Therapeutics, Maintains $84 Price Target
CRISPR Therapeutics Analyst Ratings
Cathie Wood's Ark Invest Loads Up On Amazon, Coinbase: Offloads UiPath, Roblox
CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know
Crispr Therapeutics Gets Orphan Drug Status for Lymphoma Treatment
Crispr Therapeutics Granted Orphan Status for Follicular Lymphoma Treatment
70107480 OP : I think its best to hold on to our cash, it may go Green from time to time, but there will be more Red in the days and months to come, i think.